Gastroenterology news

New biologic option for Crohn's disease

New biologic option for Crohn's disease

Patients with moderately to severely active Crohn's...

Summaries of NICE bowel disease guidance published by MIMS

Summaries of NICE bowel disease guidance published by MIMS

GPs treating patients with inflammatory bowel disease...

Movicol now available in ready-to-use sachets
Ferric maltol: new iron therapy for patients with inflammatory bowel disease

Ferric maltol: new iron therapy for patients with inflammatory bowel disease

Feraccru (ferric maltol) is licensed for the treatment...

Updated MIMS summary of H. pylori treatment regimens

Updated MIMS summary of H. pylori treatment regimens

The popular quick-reference MIMS summary of NICE guidance...

Proton pump inhibitors associated with low risk of cutaneous lupus

Proton pump inhibitors associated with low risk of cutaneous lupus

Proton pump inhibitors (PPIs) are associated with very...

Naloxone derivative launched for opioid-induced constipation

Naloxone derivative launched for opioid-induced constipation

Naloxegol (Moventig) provides a new option for the...

NICE approves vedolizumab for Crohn's disease

NICE approves vedolizumab for Crohn's disease

The integrin inhibitor vedolizumab (Entyvio) has been...

New constipation treatment receives NICE approval

New constipation treatment receives NICE approval

The constipation treatment naloxegol (Moventig) will...

Women-only constipation treatment now licensed in men

Women-only constipation treatment now licensed in men

Prescribers can now consider the 5HT4 agonist prucalopride...

Ulcerative colitis treatment recommended by NICE

Ulcerative colitis treatment recommended by NICE

Vedolizumab (Entyvio) has been accepted by NICE for...

NICE recommends drug to prevent episodes of hepatic encephalopathy

NICE recommends drug to prevent episodes of hepatic encephalopathy

Rifaximin (Targaxan) has been accepted by NICE for...

Creon 40,000 (pancreatin) unavailable

Creon 40,000 (pancreatin) unavailable

Linaclotide recommended in updated NICE IBS guideline

Linaclotide recommended in updated NICE IBS guideline

NICE guidance on the care of adults with irritable...

Cortiment: first budesonide tablet for ulcerative colitis
Remsima and Inflectra: new infliximab 'biosimilars'

Remsima and Inflectra: new infliximab 'biosimilars'

Remsima and Inflectra are the first biosimilar monoclonal...

NICE widens approval for TNF inhibitors in inflammatory bowel disease

NICE widens approval for TNF inhibitors in inflammatory bowel disease

NICE has broadened its guidance on the use of TNF-inhibiting...

News in brief - December 2014 (updated)

News in brief - December 2014 (updated)

Other new launches, licence changes and updates relevant...

News in brief - November 2014

News in brief - November 2014

Other new launches, licence changes and updates relevant...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.